Backboard versus mattress spint immobilization : A comparison of symptoms generatedCHAN, D; GOLDBERG, R. M; MASON, J et al.The Journal of emergency medicine. 1996, Vol 14, Num 3, pp 293-298, issn 0736-4679Article

Measurable or assessable disease in lung cancer trials does it matter ?JETT, J. R; SU, J. Q; KROOK, J. E et al.Journal of clinical oncology. 1994, Vol 12, Num 12, pp 2677-2681, issn 0732-183XArticle

Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexiaLOPRINZI, C. L; MICHALAK, J. C; SCHAID, D. J et al.Journal of clinical oncology. 1993, Vol 11, Num 4, pp 762-767, issn 0732-183XArticle

Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741DELAUNOIT, T; ALBERTS, S. R; FINDLAY, B. P et al.Annals of oncology. 2005, Vol 16, Num 3, pp 425-429, issn 0923-7534, 5 p.Article

A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancerACKLAND, S. P; JONES, M; MOORE, M. J et al.British journal of cancer. 2005, Vol 93, Num 11, pp 1236-1243, issn 0007-0920, 8 p.Article

Prospectively randomized north central cancer treatment group trial of intensive-course fluorouracil combined with the l-isomer of intravenous leucovorin, oral leucovorin, or intravenous leucovorin for the treatment of advanced colorectal cancerGOLDBERG, R. M; HATFIELD, A. K; TIRONA, M. T et al.Journal of clinical oncology. 1997, Vol 15, Num 11, pp 3320-3329, issn 0732-183XArticle

Drug-drug and drug-disease interactions in the ED : Analysis of a high-risk populationGOLDBERG, R. M; MABEE, J; CHAN, L et al.The American journal of emergency medicine. 1996, Vol 14, Num 5, pp 447-450, issn 0735-6757Conference Paper

A phase III evaluation of a somatostatin analogue (Octreotide) in the treatment of patients with asymptomatic advanced colon carcinomaGOLDBERG, R. M; MOERTEL, C. G; WIEAND, H. S et al.Cancer. 1995, Vol 76, Num 6, pp 961-966, issn 0008-543XArticle

Pentoxifylline for treatment of cancer anorexia and cachexia ? A randomized, double-blind, placebo-controlled trialGOLDBERG, R. M; LOPRINZI, C. L; MAILLIARD, J. A et al.Journal of clinical oncology. 1995, Vol 13, Num 11, pp 2856-2859, issn 0732-183XArticle

Cyclophosphamide, cisplatin, and leuprolide acetate in patients with debulked stage III or IV ovarian carcinomaERICKSON, L. D; HARTMANN, L. C; SU, J. Q et al.Gynecologic oncology (Print). 1994, Vol 54, Num 2, pp 196-200, issn 0090-8258Article

Phase II trial of lymphoblastoid interferon in metastatic malignant melanomaGOLDBERG, R. M; AYOOB, M; SILGALS, R et al.Cancer treatment reports. 1985, Vol 69, Num 7-8, pp 813-816, issn 0361-5960Article

Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancersHALLING, K. C; FRENCH, A. J; WITZIG, T. E et al.Journal of the National Cancer Institute. 1999, Vol 91, Num 15, pp 1295-1303, issn 0027-8874Article

Influence of erythropoietin on transfusion requirements in patients receiving preoperative chemoradiotherapy for rectal cancer. Invited editorialLEVINE, E. A; LABORDE, C; HAMBRICK, E et al.Diseases of the colon & rectum. 1999, Vol 42, Num 8, pp 1065-1071, issn 0012-3706Conference Paper

Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinomaSCHLEUSENER, J. T; TAZELAAR, H. D; SIN-HO JUNG et al.Cancer. 1996, Vol 77, Num 7, pp 1284-1291, issn 0008-543XArticle

Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumorCASCINO, T. L; VEEDER, M. H; BUCKNER, J. C et al.Journal of neuro-oncology. 1996, Vol 30, Num 3, pp 243-246, issn 0167-594XArticle

Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancerLOPRINZI, C. L; GOLDBERG, R. M; WENDER, D. B et al.Journal of clinical oncology. 1994, Vol 12, Num 6, pp 1126-1129, issn 0732-183XArticle

Randomized trial of cyclophosphamide, methotrexate, and 5-fluorouracil with or without estrogenic recruitment in women with metastatic breast cancerINGLE, J. N; FOLEY, J. F; MAILLIARD, J. A et al.Cancer. 1994, Vol 73, Num 9, pp 2337-2343, issn 0008-543XArticle

Cancer-associated anorexia and cachexia : implications for drug therapyLOPRINZI, C. L; GOLDBERG, R. M; BURNHAM, N. L et al.Drugs (Basel). 1992, Vol 43, Num 4, pp 499-506, issn 0012-6667Article

Bolus versus infusion regimens of etoposide and cisplatin in treatment of non-small cell lung cancer : a study of the North Central Cancer Treatment GroupGOLDBERG, R. M; JETT, J. R; THERNEAU, T. M et al.Journal of the National Cancer Institute. 1990, Vol 82, Num 24, pp 1899-1903, issn 0027-8874, 5 p.Article

Laryngeal burns secondary to the ingestion of microwave-heated foodGOLDBERG, R. M; LEE, S; LINE, W. S et al.The Journal of emergency medicine. 1990, Vol 8, Num 3, pp 281-283, issn 0736-4679, 3 p.Conference Paper

The ARCAD advanced colorectal cancer database—open for businessBUYSE, M; SARGENT, D. J; GOLDBERG, R. M et al.Annals of oncology. 2012, Vol 23, Num 1, pp 281-282, issn 0923-7534, 2 p.Article

Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I studyALBERTS, S. R; TOWNLEY, P. M; SARGENT, D. J et al.Annals of oncology. 2002, Vol 13, Num 4, pp 553-557, issn 0923-7534Article

Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566ERLICHMAN, C; ADJEI, A. A; ALBERTS, S. R et al.Annals of oncology. 2001, Vol 12, Num 3, pp 389-395, issn 0923-7534Article

Phase I study of the duocarmycin semisynthetic derivative KW-2189 given daily for five days every six weeksALBERTS, S. R; ERLICHMAN, C; REID, J. M et al.Clinical cancer research. 1998, Vol 4, Num 9, pp 2111-2117, issn 1078-0432Article

Is repeated treatment with a 5-fluorouracil-based regimen useful in colorectal cancer?GOLDBERG, R. M.Seminars in oncology. 1998, Vol 25, Num 5, pp 21-28, issn 0093-7754, SUP11Article